Published in Clin Biochem Rev on January 01, 2004
Traceability, reference systems and result comparability. Clin Biochem Rev (2007) 1.33
Clinical evaluation of analytical variations in serum creatinine measurements: why laboratories should abandon Jaffe techniques. BMC Nephrol (2012) 0.93
Laboratory system strengthening and quality improvement in Ethiopia. Afr J Lab Med (2014) 0.93
The Evidence Based Medicine approach to diagnostic testing: practicalities and limitations. Clin Biochem Rev (2005) 0.83
Quality assurance program for molecular medicine laboratories. Iran J Public Health (2013) 0.79
The readiness of the national health laboratory system in supporting care and treatment of HIV/AIDS in Tanzania. BMC Health Serv Res (2015) 0.78
Adding Value in the Postanalytical Phase. EJIFCC (2016) 0.75
The dynamic roles played by a biochemist. Indian J Clin Biochem (2014) 0.75
Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet (2004) 5.49
It's time for a change to a troponin standard. Circulation (2000) 2.69
Quality assessment of interpretative commenting in clinical chemistry. Clin Chem (2004) 2.49
Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem (2003) 1.51
Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol (2003) 1.42
Clinical chemistry in laboratory medicine in Europe--past, present and future challenges. Eur J Clin Chem Clin Biochem (1997) 1.41
Robotics and the changing face of the clinical laboratory. Clin Chem (1996) 1.41
Myocardial infarction redefined: the new ACC/ESC definition, based on cardiac troponin, increases the apparent incidence of infarction. Heart (2002) 1.22
Patient-specific narrative interpretations of complex clinical laboratory evaluations: who is competent to provide them? Clin Chem (2004) 1.16
Role and importance of biochemical markers in clinical cardiology. Eur Heart J (2004) 1.15
Retrospective analysis of the cost-effectiveness of using plasma brain natriuretic peptide in screening for left ventricular systolic dysfunction in the general population. J Am Coll Cardiol (2003) 1.07
Managing utilization of new diagnostic tests. Clin Leadersh Manag Rev (2003) 1.02
The need for an outcomes research agenda for clinical laboratory testing. JAMA (1998) 1.01
Audit in laboratory medicine. Eur J Clin Chem Clin Biochem (1996) 1.00
Charting the course of medical laboratories in a changing environment. Clin Chim Acta (2002) 0.96
Differences in the diagnosis of myocardial infarction by troponin T compared with clinical and epidemiologic criteria. Am J Cardiol (2001) 0.96
Laboratory-related outcomes in healthcare. Clin Chem (2001) 0.96
Acute coronary syndrome: biochemical strategies in the troponin era. Chest (2002) 0.91
Narrative interpretations for clinical laboratory evaluations: an overview. Am J Clin Pathol (2001) 0.91
Evaluation of a fully automated assay to measure C-telopeptide of type I collagen in serum. Clin Chem Lab Med (2000) 0.89
Impact of European Society of Cardiology/American College of Cardiology guidelines on diagnostic classification of patients with suspected acute coronary syndromes. Ann Clin Biochem (2003) 0.86
Understanding the clinical biochemistry of N-terminal pro-B-type natriuretic peptide: the prerequisite for its optimal clinical use. Clin Lab (2004) 0.84
Postanalytical factors and their influence on analytical quality specifications. Scand J Clin Lab Invest (1999) 0.83
Reference intervals for amylase isoenzymes in serum and plasma of infants and children. Clin Chem (1983) 0.83
Enhanced clinical consulting--moving toward the core competencies of laboratory professionals. Clin Chim Acta (2002) 0.82
The importance of imprecision. Ann Clin Biochem (1991) 0.82
The clinical importance of laboratory reasoning. Clin Chim Acta (1999) 0.81
Impact of troponin T determinations on hospital resource utilization and costs in the evaluation of patients with suspected myocardial ischemia. Am J Cardiol (2001) 0.81
Laboratory medicine in the 21st Century. Am J Clin Pathol (2000) 0.79
Interpretative comments and reference ranges in EQA programs as a tool for improving laboratory appropriateness and effectiveness. Clin Chim Acta (2003) 0.79
Hyperamylasemia after cardiac surgery in infants and children. Intensive Care Med (1996) 0.78
The national health system: future possibilities for the clinical laboratory. Clin Chim Acta (2002) 0.78
Clinical evaluation of an algorithm for the interpretation of hyperamylasemia. Arch Pathol Lab Med (1991) 0.77
Which surrogate marker can be used to assess the effectiveness of the laboratory and its contribution to clinical outcome? Ann Clin Biochem (2001) 0.77
Defining/measuring the value of clinical information. Clin Leadersh Manag Rev (2001) 0.77
Laboratory costs in the context of disease. Clin Chem (2000) 0.77
The changing face of clinical laboratories. Clin Chem Lab Med (1999) 0.77
Rational use of clinical chemistry investigations: from diagnoses to processes. Ann Clin Biochem (1998) 0.77
Good laboratory practice: the medical aspects. Eur J Clin Chem Clin Biochem (1997) 0.77
Troponin T: role in altering patient management and enabling earlier discharge from a district general hospital. Ann Clin Biochem (2001) 0.77